Targeting Inflammation in Atherosclerosis: CANTOS Trial | Dr Paul Ridker

from The Radcliffe Cardiology Podcast · host The Radcliffe Cardiology Podcast

Prof Paul Ridker (Brigham and Women’s Hospital, Boston, US) provides us with an overview of the CANTOS main trial results and updated results from the ACC 2022. Supported by an unrestricted educational grant from NOVO NORDISK A/S.

Episode metadata supplied by the publisher feed · Published Apr 19, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

Targeting Inflammation in Atherosclerosis: CANTOS Trial | Dr Paul Ridker

0:00 6:19

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Radcliffe Cardiology Podcast?

This episode is 6 minutes long.

When was this The Radcliffe Cardiology Podcast episode published?

This episode was published on April 19, 2022.

Can I download this The Radcliffe Cardiology Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!